Paths of Progress 2023

Posted date



The articles below are featured in the 2023 issue of our Paths of Progress magazine. To see the entire publication, which includes Dana-Farber's 2022 Annual Report, please download the PDF version.


One Drug, Two Targets

Bispecific antibodies are new cancer drugs modeled after the body's own disease-fighting antibodies, but with a sort of superpower: They can bind to two different targets at one time.

Finding Pancreatic Cancer Earlier

How Dana-Farber is transforming the narrative in the early detection and treatment of a stubborn cancer.

The Power of Plus

Combining immunotherapy with other treatments shows great promise against certain cancers. Dana-Farber researchers are working to enhance its effectiveness, target more types of cancer, and lengthen remissions.

50 Years of Stem Cell Transplants

Five decades of scientific effort have made Dana-Farber a worldwide leader in stem cell transplants, transforming the lives of thousands of patients.

Request a Publication

Receive by mail the current issue of a Dana-Farber publication by completing this request form.

Request a Publication

Media Contacts

If you are a journalist and have a question about any of our stories or need more information, email or call 617-632-4090 and ask to speak to a member of the media team.

The Media Team cannot respond to patient inquiries. For more information on contacting Dana-Farber, please see Contact Us.